Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgment of Support
This educational activity is supported by educational grants from Jazz Pharmaceuticals, Inc. and Novartis Pharmaceuticals Corporation.
Advances In™ Lung Cancer: Primary Investigators Present Key Abstracts
Release Date: August 26, 2020
Expiration Date: August 26, 2021
This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of lung cancer, with a forward-looking perspective on how new and novel agents might impact clinical practice. New evidence from recently presented key abstracts in lung cancer management will be discussed including how these data fit in the context of current management paradigms in the field and how clinicians should consider these findings with regard to their practices. The information will be presented in a multimedia format, including a series of video interviews with expert thought leaders integrated into text-based elements.
Acknowledgement of Commercial Support
This activity is supported by educational grants from Jazz Pharmaceuticals, Inc. and Novartis Pharmaceuticals Corporation.
Instructions for This Activity and Receiving Credit
You may immediately download your certificate.
This educational activity is directed toward medical oncologists and fellows who treat patients with lung cancer. Surgical oncologists, radiation oncologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of lung cancer will be invited to participate
Upon successful completion of this activity, you should be better prepared to:
• Evaluate recently reported clinical trial data applicable to the care of patients with lung cancer
• Integrate emerging data into a plan of care to optimize outcomes for patients with lung cancer
• Assess patient eligibility for ongoing lung cancer clinical trials and treatment regimens under investigation
Faculty, Staff, and Planners’ Disclosures
In accordance with ACCME guidelines, PER® has identified and resolved all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Head of Medical Oncology Department
Associate Professor, Universidad Complutense de Madrid
Hospital Universitario 12 de Octubre
Disclosures: Luis Paz-Ares Rodriguez, MD has no relevant financial relationships with commercial interest to disclose.
Associate Professor of Medicine
Harvard Medical School
Massachusetts General Cancer Center
Disclosures: Grant Research Support: Dr. Heist reports grants during the conduct of the study given to the institution from Novartis, Abbvle, Agios, Daichi Sankyo, Corvus, Genentech Roche, Mirati, Exelixis, Debiopharm, lncyte, Takeda, Lilly; Honoraria/Consulting: Novartis, Apollomlcs, Tarveda, Boehringer lngelheim, Pfizer, Roche.
The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
Login or Register to Start Activity
Please use the form below to Register or Log In to begin Activity.